Bavencio 20 mg/mL concentrate for solution for infusion
MS100070_0176
Phase 3 small_molecule active
Quick answer
Bavencio 20 mg/mL concentrate for solution for infusion for Solid Tumors is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Solid Tumors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active